Cited by

• Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics.

  Gamwell LF, Gambaro K, Merziotis M, Crane C, Arcand SL, Bourada V, Davis C, Squire JA, Huntsman DG, Tonin PN, Vanderhyden BC. Gamwell LF, et al. Orphanet J Rare Dis. 2013 Feb 21;8:33. doi: 10.1186/1750-1172-8-33. Orphanet J Rare Dis. 2013. PMID: 23433318 Free PMC article.
• Interfering with tumor pathways that augment viral oncolysis.

  Bell JC. Bell JC. Mol Ther. 2011 Dec;19(12):2108-9. doi: 10.1038/mt.2011.253. Mol Ther. 2011. PMID: 22134743 Free PMC article. No abstract available.
• Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

  Do WL, Wang L, Forgues M, Liu J, Rabibhadana S, Pupacdi B, Zhao Y, Gholian H, Bhudhisawasdi V, Pairojkul C, Sukeepaisarnjaroen W, Pugkhem A, Luvira V, Lertprasertsuke N, Chotirosniramit A, Auewarakul CU, Ungtrakul T, Sricharunrat T, Sangrajrang S, Phornphutkul K, Budhu A, Harris CC, Mahidol C, Ruchirawat M, Wang XW. Do WL, et al. Cell Rep Med. 2023 Dec 19;4(12):101328. doi: 10.1016/j.xcrm.2023.101328. Cell Rep Med. 2023. PMID: 38118412 Free PMC article.
• Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesothelioma.

  Willmon CL, Saloura V, Fridlender ZG, Wongthida P, Diaz RM, Thompson J, Kottke T, Federspiel M, Barber G, Albelda SM, Vile RG. Willmon CL, et al. Cancer Res. 2009 Oct 1;69(19):7713-20. doi: 10.1158/0008-5472.CAN-09-1013. Epub 2009 Sep 22. Cancer Res. 2009. PMID: 19773437 Free PMC article.
• Mesenchymal stem/stromal cells in cancer therapy.

  Lan T, Luo M, Wei X. Lan T, et al. J Hematol Oncol. 2021 Nov 17;14(1):195. doi: 10.1186/s13045-021-01208-w. J Hematol Oncol. 2021. PMID: 34789315 Free PMC article. Review.